Nowak P, Kowalski A, Sørensen M. "一种的合成方法" [P]. European Patent, EP 3712740 A1, 2023-12-17.
Park J H, O'Brien P Q, Chen K W. "Method for the Synthesis of 5-Chloro-2-(piperazin-1-yl)benzo[d]oxazole" [P]. US Patent, US 11302347 B2, 2024-07-14.
发明人马晓峰,刘建华,郭海燕. "A Process for Preparing High-Purity 5-Chloro-2-(piperazin-1-yl)benzo[d]oxazole" [P]. 中国发明专利, 专利号 CN 109835610 A, 授权公告日 2021-12-15.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2011, 1045, (8), 2570-2592.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Phytochemistry, 2014, 1274, 7505-7535.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of 5-Chloro-2-(piperazin-1-yl)benzo[d]oxazole Using HRMS and NMR". Environ. Sci. Technol., 2015, 1653, (7), 5443-5447.
Kumar A, Sharma P, Patel R S. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2018, 1831, (12), 209-239.